Chinese scientists report they are ahead of international competitors in developing stem cell therapies for Parkinson's disease. They cite greater efficiency and faster clinical trial timelines for their advancements.

Chinese researchers claim to be outpacing international competitors in the development of stem cell therapies for Parkinson’s disease, citing higher efficiency and a faster clinical trial timeline. Parkinson’s is often described as a movement disorder. Its symptoms are caused by the brain’s failure to produce sufficient dopamine, because of the death or dysfunction of the specialised neurons responsible for generating the chemical. In the search for a cure, researchers around the world are...